Post Test, Evaluation, and Credit Application Form

Please note that to receive credit you must achieve a score of at least 70%.

Physicians: Certificate of Credit will be emailed within 4 weeks of successful completion of the activity.

Pharmacists: The information that you participated will be uploaded to CPE Monitor within 4 weeks of successful completion of the activity and you will be able to access your credits from the profile you set up with NABP. For more information, please visit http://www.nabp.net/.

Question Title

1. The herpes zoster vaccine is best described as a:

Inactivated viral vaccine.

Live, attenuated viral vaccine.

Inactivated toxin.

Conjugate vaccine.

Question Title

2. The Advisory Committee on Immunization Practices (ACIP) recommends administering the herpes zoster vaccine beginning at age:

50 years.

55 years.

60 years.

65 years.

Question Title

3. Which of the following is the proper way to store herpes zoster vaccine?

At room temperature indefinitely.

As a lyophilized powder until ready to use.

Refrigerated until ready to use.

Kept frozen until immediately prior to use.

Question Title

4. The herpes zoster vaccine can be safely given to all of the following patients except:

Those with congestive heart failure.

HIV infected persons.

Those who received the pneumococcal vaccine in the previous 2 months.

Those who had an episode of shingles in the past year.

Question Title

5. In considering giving the herpes zoster vaccine to a grandmother who is now caring for a newborn, the vaccine should be given:

Immediately.

When the newborn is 2 months of age.

When the newborn is 6 months of age.

When the newborn is 12 months of age.

Question Title

6. When is the ideal time to administer the herpes zoster vaccine for a patient who currently has shingles?

Immediately.

Once the symptoms of infection resolve.

At least 1 year following the infection.

Never. The patient is now immune to future herpes zoster infections.

Question Title

7. A frequent serious long-term consequence of herpes zoster infection is:

Retinopathy.

Metastatic melanoma.

Post-herpetic neuralgia.

Hepatic dysfunction.

Question Title

8. Compared to ACIP recommendations, the FDA recommends administering the herpes zoster vaccine:

At a younger age.

At an older age.

Only to immunocompromised adults.

Only to those who confirm having chickenpox as a child.

Question Title

9. Administration of the herpes zoster vaccine should be deferred if the patient cannot remember whether he/she received the vaccine in the past.

True

False

Question Title

10. A healthy person who received the herpes zoster vaccine at 62 years of age should receive a booster shot:

In 6 months.

After 1 year.

After 5 years.

Never.